Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tonix

Steve Cohen's Point72 Buys $20M of Biotech Stock Advancing Depression Treatment

Point72 Asset Management purchased over 1.2 million shares of Tonix Pharma at $16.28 each as the company aggressively advances its drug development programmes.

International Business Times UK

What's Going On With Tonix Pharmaceuticals (TNXP) Stock?

Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have rallied 30% over the past five sessions, though are marginally lower Thursday afternoon, as investors anticipate a key catalyst for the company.

Benzinga

Why Tonix Pharmaceuticals (TNXP) Stock Is Climbing This Week

Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) are building on recent gains, trading higher as investor focus intensifies on a key, upcoming catalyst. Here’s what investors need to know.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Tonix Pharmaceuticals (TNXP) Stock Surges On Q2 Earnings Beat And Upcoming FDA Catalyst

Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) are trading sharply higher Tuesday morning following the release of the company’s second-quarter financial results and operational update.

Benzinga

Pharma Frenzy: Volatility Ignites Biotech Sector

Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value.

MarketBeat

Is Tonix Pharmaceuticals the Next Biotech Breakout?

Tonix Pharmaceuticals' innovative approach to fibromyalgia treatment positions the company for substantial market disruption and long-term growth.

MarketBeat

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Avalo Therapeutics (NASDAQ:AVTX) has dosed the first patient in the pivotal LADDER trial to assess the efficacy and safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) ER). Avalo shares traded in a range of $3.5 to $3.91 on a day volume of 33.54 thousand shares,…

Benzinga

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

EXCLUSIVE: Tonix Pharmaceuticals CEO Highlights Advantages Of Company's Monkeypox Vaccine In Development

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are soaring Monday after the World Health Organization (WHO) declared monkeypox a public health emergency of global concern.

Benzinga

What's Going On With Tonix Pharmaceuticals Shares Today?

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 6.03% to $2.96 during Thursday’s pre-market session. The company announced Thursday that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq.

Benzinga

Mid-Day Market Update: Dow Dips 200 Points; Tonix Pharmaceuticals Shares Spike Higher

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Wednesday.

Benzinga

EXCLUSIVE: Tonix CEO Seth Lederman On The Pursuit Of New Monkeypox, COVID Vaccines

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a Chatham, New Jersey-based clinical-stage biopharmaceutical company, announced on Wednesday the issuance of a patent that forms the basis for the company's developmental vaccine against monkeypox and smallpox.

Benzinga

Why Tonix Pharmaceuticals Stock Is Soaring

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading higher Wednesday after the company announced that the United States Patent and Trademark Office issued a patent to Tonix titled, "Synthetic Chimeric Poxviruses."

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

6 Stocks To Watch Amid Monkeypox Outbreak

A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts.

Benzinga

Tonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has

Benzinga

Tonix Says Fibromyalgia Candidate Failed To Achieve Statistical Significance Over Placebo

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) says that as expected, TNX-102 SL (cyclobenzaprine HCl sublingual tablets)

Benzinga

Tonix Pharmaceuticals Rockets Higher Thursday: Why Is The Penny Stock Flying?

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares are rallying higher Thursday after the company announced the FDA has granted Orphan-Drug Designation for TNX-2900 for the treatment of Prader-Willi syndrome.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Tonix Pharma Inks Research Pact For Oxytocin In Eating Disorder

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

National Institutes of Health

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.